of 5
Featured News
Some of the leading stories and synthetic biology information from SynbiCITE
21 Jul 2017
A vibrant synthetic biology ecosystem has developed in the UK – promising new jobs and valuable technology
A survey of synthetic biology company start-ups in the UK is published today by SynbiCITE, the UK’s national centre for the commercialisation of synthetic biology. The study reveals a vibrant ecosystem sustaining a thriving and rapidly growing sector of the bioeconomy.
10 Oct 2017
Prominent players in the UK’s thriving synbio sector
SynbiCITE looks at some of the companies leading the way in UK synthetic biology, creating innovative new technologies and driving the growth of the UK bioeconomy.
UK Synthetic Biology start-up survey 2017
The UK’s first survey of the Synthetic Biology industry following a year of significant progress.
SynbiCITE’s UK Synthetic Biology start-up survey 2017 will assess the current and potential size of the Synthetic Biology industry, looking closely at growth trends, company scale, the value of the sector, key stakeholders and the commercial impact it could have. The challenges facing the industry, such as funding and IP protection, regulatory issues and ethics will also be evaluated. The completed report will be available this summer.
SynbiCITE has created a globally renowned national resource of interacting partners from academia, industry and business across the UK to accelerate the commercialisation of world-class science and emerging technologies encompassed by synthetic biology into new products, tools, processes and services.
Innovation, education & collaboration
Watch SynbiCITE's new film to get an insight into the potential that synthetic biology offers us all.
Synthetic biology is unlocking significant new opportunities for industries ranging from life sciences and specialty chemicals to bioenergy and waste remediation. By facilitating the creation of new tools and techniques, synbio has the potential to reshape many technologies to affect our lives positively and to reduce the impact that we have on our planet. Synbio is the engineering of biology and it’s already helping to make many businesses more effective, more productive and more environmentally friendly.
SynbiCITE has created a globally renowned national resource of interacting partners from academia, industry and business across the UK which accelerates the commercialisation of world-class science and the emerging technologies encompassed by synthetic biology and engineering biology into new products, tools, processes and services.
We partner with some of the world’s most forward-thinking organisations
We support our partners through events and training programmes including problems-solutions brokerage meetings. We provide funding of development projects including seed funding of Proof of Concept projects and follow-on funding of longer, larger projects for the development of prototypes and taking these on to pilot production scale manufacturing.
View our network
Synthetic Biology community
Take a look at the active and interactive synthetic biology community. Join the conversation and get involved.
Back to Basics Agilent Seminar Series: Introduction to Sample Preparation
25 October 2017
Prominent players in the UK’s thriving synbio sector
SynbiCITE looks at some of the companies leading the way in UK synthetic biology, creating innovative new technologies and driving the growth of the UK bioeconomy.
Synthetic biology companies show significant growth at KTN Showcase https://t.co/BjVFGrCYon
Stephen Chambers
- 0
- 0
Our favourite plot here at the foundry! @JMP_software #dataviz @SASsoftware @JMP_tips https://t.co/85TdcnUQqK
London DNA Foundry
- 4
- 2
Snack time just got political with these GM apples - via @techreview https://t.co/7hI53CRC4F
Stephen Chambers
- 0
- 0
.@SynbiCITE & @Fieldfisher's #Synbio & #IP masterclass for tech transfer officers in Nov. Register now https://t.co/P0PZC5Fg9B #engbio
SynbiCITE
- 2
- 0
FDA approves cancer treatment for ‘patients without hope’ after Boston studies #CAR_T @GileadSciences @KitePharma https://t.co/j0Wj6rv5Ho
Stephen Chambers
- 2
- 1
.@SynbiCITE congratulates @synpromics on winning Best Emerging UK #Synbio Company @OBN_UK Awards!… https://t.co/WgttcbWFYB
SynbiCITE
- 1
- 2
Biotech fragrance maker @Ginkgoo teams with @transcriptic Robotics https://t.co/T0OdtiJXL5
Stephen Chambers
- 1
- 2
.@Arborea_Ltd: the start-up trying to save the world https://t.co/c6Ts5KAiRU supported by @SynbiCITE #innovation #synbio #globalwarming
SynbiCITE
- 5
- 4
Synpromics announced as Best Emerging UK Synthetic Biotech Company at OBN Awards 2017
SynbiCITE congratulates Synpromics as the winner of Best Emerging UK Synthetic Biotech Company at OBN’s 9th Annual Awards.
Synthace raises £7.3m to accelerate biotechnology to enable faster breakthroughs
The Company’s Antha operating system brings end-to-end digitization to biotechnology, replacing current artisanal methods of development Speaking...